美国 · SEC FORM 4
ALNYLAM PHARMACEUTICALS, INC.
ALNY · Nasdaq · CIK 0001178670 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
18 同一窗口内观察到的 Form 4 交易行
6 sales · 12 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 5 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-10-17 · Reitan Colleen F.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -17.1%
- 3M
- -29.2%
- 6M
- -30.5%
- 12M
- —
波动率与流动性
- 波动率
- 48.0%
- Beta
- —
- 平均每日成交额
- —
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- 8.4%
- ROE
- 39.8%
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-02 · 价格来源：OpenBB/yfinance · 来自 SEC 申报文件：利润率, ROE · 财年截止日：2025-12-31 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 7,711,495
- 上期报告
- 7,194,097
- 日均成交量
- 1,195,107
- 回补天数
- 6.5
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
Form 4 申报证据
321 transaction lines in the latest 365-day window; 1,327 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | SUPRAN BRYAN | 卖出 (S) | Common Stock | 1,758 | USD 226.88 | USD 398,855 | SEC 申报 ↗ |
| 2026-09-19 | Greenstreet Yvonne | 奖励／授予 (A) | Common Stock | 107 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-01 | PYOTT DAVID E I | 卖出 (S) | Common Stock | 3,830 | USD 299.18 | USD 1,145,853 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | SUPRAN BRYAN | 卖出 (S) | Common Stock | 1,758 | USD 226.88 | USD 398,855 | SEC 申报 ↗ |
| 2026-09-19 | Greenstreet Yvonne | 奖励／授予 (A) | Common Stock | 107 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-06-01 | PYOTT DAVID E I | 卖出 (S) | Common Stock | 3,830 | USD 299.18 | USD 1,145,853 | SEC 申报 ↗ |
| 2026-06-01 | PYOTT DAVID E I | 期权行权／转换 (M) | Common Stock | 3,830 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Sigal Charles Elliott | 奖励／授予 (A) | Common Stock | 671 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | SCHULMAN AMY W | 奖励／授予 (A) | Common Stock | 838 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Reitan Colleen F | 奖励／授予 (A) | Common Stock | 671 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | PYOTT DAVID E I | 奖励／授予 (A) | Common Stock | 671 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | KELLOGG PETER N | 奖励／授予 (A) | Common Stock | 671 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | HAMBURG MARGARET A | 奖励／授予 (A) | Common Stock | 671 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | BRANDICOURT OLIVIER | 奖励／授予 (A) | Common Stock | 671 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Ausiello Dennis A | 奖励／授予 (A) | Common Stock | 671 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-20 | Arbuckle Stuart A | 奖励／授予 (A) | Common Stock | 671 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-05-13 | SCHULMAN AMY W | 期权行权／转换 (M) | Common Stock | 11,250 | USD 70.20 | USD 789,750 | SEC 申报 ↗ |
| 2026-04-06 | McLaughlin Melissa | 卖出 (S) | Common Stock | 2,286 | USD 330.42 | USD 755,329 | SEC 申报 ↗ |
| 2026-04-02 | McLaughlin Melissa | 卖出 (S) | Common Stock | 1,624 | USD 319.59 | USD 519,014 | SEC 申报 ↗ |
| 2026-03-05 | Garg Pushkal | 卖出 (S) | Common Stock | 2,404 | USD 323.96 | USD 778,812 | SEC 申报 ↗ |
| 2026-03-05 | Fitzgerald Kevin Joseph | 卖出 (S) | Common Stock | 658 | USD 323.98 | USD 213,177 | SEC 申报 ↗ |
| 2026-03-04 | Tanguler Tolga | 卖出 (S) | Common Stock | 2,309 | USD 323.08 | USD 745,984 | SEC 申报 ↗ |
| 2026-03-04 | Poulton Jeffrey V. | 卖出 (S) | Common Stock | 2,468 | USD 323.08 | USD 797,351 | SEC 申报 ↗ |
| 2026-03-04 | Greenstreet Yvonne | 卖出 (S) | Common Stock | 2,933 | USD 323.08 | USD 947,581 | SEC 申报 ↗ |
| 2026-03-04 | Garg Pushkal | 卖出 (S) | Common Stock | 2,309 | USD 323.08 | USD 745,984 | SEC 申报 ↗ |
| 2026-03-04 | Fitzgerald Kevin Joseph | 卖出 (S) | Common Stock | 633 | USD 323.08 | USD 204,508 | SEC 申报 ↗ |
| 2026-03-03 | Garg Pushkal | 卖出 (S) | Common Stock | 1,775 | USD 319.74 | USD 567,546 | SEC 申报 ↗ |
| 2026-03-03 | Fitzgerald Kevin Joseph | 卖出 (S) | Common Stock | 1,652 | USD 319.73 | USD 528,189 | SEC 申报 ↗ |
| 2026-03-02 | Tanguler Tolga | 卖出 (S) | Common Stock | 1,598 | USD 327.65 | USD 523,584 | SEC 申报 ↗ |
| 2026-03-02 | Tanguler Tolga | 奖励／授予 (A) | Common Stock | 4,769 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-02 | SUPRAN BRYAN | 奖励／授予 (A) | Common Stock | 1,539 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-03-02 | Poulton Jeffrey V. | 卖出 (S) | Common Stock | 2,206 | USD 327.65 | USD 722,801 | SEC 申报 ↗ |
| 2026-03-02 | Poulton Jeffrey V. | 奖励／授予 (A) | Common Stock | 4,769 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | ALNY |
| CIK | 0001178670 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 1,327 transaction lines from 2020-01-03 to 2026-10-02 2 P purchase lines · 997 S sale lines · 328 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.